Aspire Biopharma Holdings Income Statement (2021-2026) | ASBP

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.00M0.00M0.03M
Cost of Revenue (Quarter) 0.00M0.01M0.02M
Gross Profit (Quarter) 884.00-0.00M0.01M
Operating items
Research & Development (Quarter) 0.09M0.01M0.01M0.10M0.26M0.05M0.21M0.09M0.33M
Selling, General & Administrative (Quarter) 755.000.11M0.30M0.26M0.31M0.32M0.29M0.32M0.40M0.13M0.09M0.19M0.53M15.07M0.40M0.51M1.66M1.02M
Restructuring Costs (Quarter) 0.09M0.40M
Other Operating Expenses (Quarter) 0.01M-0.09M0.02M0.04M0.22M-0.04M0.43M0.10M0.30M
Operating Expenses (Quarter) 755.000.11M0.30M0.26M0.31M0.32M0.29M0.32M0.40M0.23M0.10M0.22M0.67M15.56M0.80M1.15M1.85M1.65M
Operating Income (Quarter) -0.22M-0.67M-15.56M-1.15M-1.85M-1.65M
EBIT (Quarter) -0.22M-0.67M-15.56M-1.15M-1.85M-1.65M
Non-operating items
Interest & Investment Income (Quarter) 0.02M0.42M1.33M2.54M3.20M2.10M0.26M0.26M0.23M0.17M
Other Non Operating Income (Quarter) -0.09M-0.29M0.78M1.17M0.25M
Non Operating Income (Quarter) 0.02M0.42M1.33M2.54M3.20M2.10M0.26M0.25M0.06M-0.10M-0.38M-1.18M-0.70M-2.86M-1.58M
Net income details
EBT (Quarter) -0.22M-0.60M-15.94M-2.63M-8.08M-3.22M
Tax Provisions (Quarter) 0.00M
Profit After Tax (Quarter) -755.00-0.09M0.12M1.08M2.23M2.87M1.81M-0.07M-0.15M-0.23M-0.10M-0.22M-0.77M-15.94M-1.98M-1.85M-4.71M-3.22M
Income from Continuing Operations (Quarter) -0.22M-0.60M-15.94M-2.63M-8.08M-3.22M
Consolidated Net Income (Quarter) -0.22M-0.60M-15.94M-2.63M-8.08M-3.22M
Income towards Parent Company (Quarter) -0.22M-0.60M-15.94M-2.63M-8.08M-3.22M
Net Income towards Common Stockholders (Quarter) -755.00-0.04M0.02M0.86M-0.09M0.57M1.47M-0.07M-0.11M-2.47M-0.60M-0.22M-0.60M-15.94M-2.63M-8.08M-3.22M
Additional items
EPS (Basic) (Quarter) -2.091.2042.84-4.4028.5672.85-3.44-5.42-122.65-29.94-9.40-25.90-504.87-63.62-162.20-20.57
EPS (Diluted) (Quarter) -9.40-25.90-504.87-63.62-162.20-20.57
Shares Outstanding (Quarter) 0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.03M0.03M0.04M0.05M0.16M
Shares Outstanding (Diluted) (Quarter) 0.02M0.02M0.03M0.03M0.04M0.05M0.16M
Shares Outstanding (Entity) (Quarter) 0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.03M0.04M0.04M0.05M0.17M
EBITDA (Quarter) -0.22M-0.67M-15.56M-1.15M-1.85M-1.65M
Interest Expenses (Quarter) 0.18M0.12M-0.07M0.29M0.53M1.48M6.23M1.60M
Tax Rate (Quarter) -0.47%